BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

782 related articles for article (PubMed ID: 26162783)

  • 21. Staphylococcus aureus endocarditis: a consequence of medical progress.
    Fowler VG; Miro JM; Hoen B; Cabell CH; Abrutyn E; Rubinstein E; Corey GR; Spelman D; Bradley SF; Barsic B; Pappas PA; Anstrom KJ; Wray D; Fortes CQ; Anguera I; Athan E; Jones P; van der Meer JT; Elliott TS; Levine DP; Bayer AS;
    JAMA; 2005 Jun; 293(24):3012-21. PubMed ID: 15972563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Periannular complications in infective endocarditis involving native aortic valves.
    Anguera I; Miro JM; Evangelista A; Cabell CH; San Roman JA; Vilacosta I; Almirante B; Ripoll T; Fariñas MC; Anguita M; Navas E; Gonzalez-Juanatey C; Garcia-Bolao I; Muñoz P; de Alarcon A; Sarria C; Rufi G; Miralles F; Pare C; Fowler VG; Mestres CA; de Lazzari E; Guma JR; Moreno A; Corey GR;
    Am J Cardiol; 2006 Nov; 98(9):1254-60. PubMed ID: 17056342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. One-year mortality in coagulase-negative Staphylococcus and Staphylococcus aureus infective endocarditis.
    Rasmussen RV; Snygg-Martin U; Olaison L; Andersson R; Buchholtz K; Larsen CT; Hansen TF; Køber L; Hassager C; Bruun NE
    Scand J Infect Dis; 2009; 41(6-7):456-61. PubMed ID: 19396665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk score for cardiac surgery in active left-sided infective endocarditis.
    Olmos C; Vilacosta I; Habib G; Maroto L; Fernández C; López J; Sarriá C; Salaun E; Di Stefano S; Carnero M; Hubert S; Ferrera C; Tirado G; Freitas-Ferraz A; Sáez C; Cobiella J; Bustamante-Munguira J; Sánchez-Enrique C; García-Granja PE; Lavoute C; Obadia B; Vivas D; Gutiérrez Á; San Román JA
    Heart; 2017 Sep; 103(18):1435-1442. PubMed ID: 28432158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for in-hospital mortality in infective endocarditis: five years' experience at a tertiary care hospital in Turkey.
    Erbay AR; Erbay A; Canga A; Keskin G; Sen N; Atak R; Demir AD; Balbay Y; Duru E
    J Heart Valve Dis; 2010 Mar; 19(2):216-24. PubMed ID: 20369506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic Assessment of Infective Endocarditis Using Echocardiography: What Is New?
    Erwin JP; O'Gara P
    Circ Cardiovasc Imaging; 2015 Jul; 8(7):e003791. PubMed ID: 26162784
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of Outcome of Possible Versus Definite Infective Endocarditis Involving Prosthetic or Bioprosthetic Heart Valves.
    Fauchier L; Pericart L; Bourguignon T; Genet T; Bisson A; Bernard A; Bernard L; Babuty D
    Am J Cardiol; 2017 Nov; 120(10):1884-1890. PubMed ID: 28917497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endocarditis caused by Staphylococcus aureus: A reappraisal of the epidemiologic, clinical, and pathologic manifestations with analysis of factors determining outcome.
    Fernández Guerrero ML; González López JJ; Goyenechea A; Fraile J; de Górgolas M
    Medicine (Baltimore); 2009 Jan; 88(1):1-22. PubMed ID: 19352296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age adjusted Charlson Co-morbidity Index is an independent predictor of mortality over long-term follow-up in infective endocarditis.
    Lu KJ; Kearney LG; Ord M; Jones E; Burrell LM; Srivastava PM
    Int J Cardiol; 2013 Oct; 168(6):5243-8. PubMed ID: 23978361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early surgical therapy of infective endocarditis in children: a 15-year experience.
    Shamszad P; Khan MS; Rossano JW; Fraser CD
    J Thorac Cardiovasc Surg; 2013 Sep; 146(3):506-11. PubMed ID: 23312102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rifampin for Surgically Treated Staphylococcal Infective Endocarditis: A Propensity Score-Adjusted Cohort Study.
    Shrestha NK; Shah SY; Wang H; Hussain ST; Pettersson GB; Nowacki AS; Gordon SM
    Ann Thorac Surg; 2016 Jun; 101(6):2243-50. PubMed ID: 26872729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term outcome of infective endocarditis in non-intravenous drug users.
    Martínez-Sellés M; Muñoz P; Estevez A; del Castillo R; García-Fernández MA; Rodríguez-Créixems M; Moreno M; Bouza E;
    Mayo Clin Proc; 2008 Nov; 83(11):1213-7. PubMed ID: 18990319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of vancomycin minimal inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus endocarditis.
    Cervera C; Castañeda X; de la Maria CG; del Rio A; Moreno A; Soy D; Pericas JM; Falces C; Armero Y; Almela M; Ninot S; Pare JC; Mestres CA; Gatell JM; Marco F; Miro JM;
    Clin Infect Dis; 2014 Jun; 58(12):1668-75. PubMed ID: 24647021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coagulase-negative staphylococcal prosthetic valve endocarditis--a contemporary update based on the International Collaboration on Endocarditis: prospective cohort study.
    Chu VH; Miro JM; Hoen B; Cabell CH; Pappas PA; Jones P; Stryjewski ME; Anguera I; Braun S; Muñoz P; Commerford P; Tornos P; Francis J; Oyonarte M; Selton-Suty C; Morris AJ; Habib G; Almirante B; Sexton DJ; Corey GR; Fowler VG;
    Heart; 2009 Apr; 95(7):570-6. PubMed ID: 18952633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of pathogenetic factors on prognosis in patients with native valve infective endocarditis.
    Abramczuk E; Hryniewiecki T; Stepińska J
    Kardiol Pol; 2006 Jul; 64(7):675-81; discussion 682-3. PubMed ID: 16886124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Predictors of hospital mortality in 186 cases of active infective endocarditis treated in a tertiary medical center (1992-2001)].
    Horacio Casabé J; Deschle H; Cortés C; Stutzbach P; Hershson A; Nagel C; Guevara E; Torino A; Raffaelli H; Favaloro RR; Suárez LD
    Rev Esp Cardiol; 2003 Jun; 56(6):578-85. PubMed ID: 12783733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated troponin level as a predictor of inpatient mortality in patients with infective endocarditis in the Southeast United States.
    Lorson W; Veve MP; Heidel E; Shorman MA
    BMC Infect Dis; 2020 Jan; 20(1):24. PubMed ID: 31914949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of outcomes in patients with active infective endocarditis with versus without paravalvular abscess and with and without valve replacement.
    Langiulli M; Salomon P; Aronow WS; McClung JA; Belkin RN
    Am J Cardiol; 2004 Jul; 94(1):136-7. PubMed ID: 15219527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Left-sided native valve infective endocarditis: Influence of age and the presence of underlying heart disease].
    Castillo Bernal FJ; Anguita Sánchez MP; Castillo Domínguez JC; Carrasco Ávalos F; Ruiz Ortiz M; Delgado Ortega M; Romo Peñas E; Mesa Rubio D; Suárez de Lezo Cruzconde J
    Med Clin (Barc); 2016 Dec; 147(11):475-480. PubMed ID: 27692625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Staphylococcus lugdunensis infective endocarditis: a literature review and analysis of risk factors.
    Liu PY; Huang YF; Tang CW; Chen YY; Hsieh KS; Ger LP; Chen YS; Liu YC
    J Microbiol Immunol Infect; 2010 Dec; 43(6):478-84. PubMed ID: 21195974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.